Skip to content
Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0311bb03-64fe-4199-95f5-4523174b9bfd&Preview=1
Date
6/5/2013
Company Name
Akebia Therapeutics
Mailing Address
9987 Carver Rd. Cincinnati, OH 45242
Company Description
Akebia Therapeutics is a venture-backed start-up pharmaceutical company with a focus on treatments for ischemia and improvement of vascular disease.
Website
http://www.akebia.com
Transaction Type
Venture Equity
Transaction Amount
$41,000,000
Transaction Round
Series C
Proceeds Purposes
The proceeds of this financing will be used to fund the ongoing development of AKB-6548, the Company’s lead clinical compound.
M&A Terms
Venture Investor
Satter Investment Management
Venture Investor
Novartis Venture Fund
Venture Investor
Kearny Venture Partners
Venture Investor
Venture Investors
Venture Investor
Athenian Venture Partners
Venture Investor
Triathlon Medical Ventures
Venture Investor
AgeChem Venture Fund
Venture Investor
Sigvion Capital
Post navigation